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Abstract 
Alpha-lipoic acid is an organosulphur compound well-known for its therapeutic potential 
and antioxidant properties. However, the effective use of α-lipoic acid depends on bio-
logical plasma half-life and its preserving stability, which could be improved by encapsul-
ation. In this study, α-lipoic acid was incorporated into chitosan microparticles obtained by
reverse emulsion crosslinking technique, as well as into microparticles of alginate/gelatin
crosslinked with zinc ions. Encapsulation of α-lipoic acid in both cases was carried out by
swelling of synthesized dried microparticles by their dipping in a solution of the active sub-
stance under strictly controlled conditions. Encapsulation efficiency of α-lipoic acid 
obtained in this study was up to 53.9%. The structural interaction of α-lipoic acid with the 
carriers was revealed by Fourier transform infrared spectroscopy. In vitro released studies 
showed that controlled release of α-lipoic acid was achieved through its encapsulation into
chitosan microparticles. The results of in vitro antioxidative activity assays of released
α-lipoic acid indicated that antioxidant activity was preserved at a satisfactory level. These 
obtained results suggested that chitosan microparticles could be suitable for modeling the
controlled release of α-lipoic acid. 
Keywords: alpha-lipoic acid, microparticles, chitosan, sodium alginate/gelatin, antioxidant 
activity. 
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Alpha-lipoic acid (LA), also known as 1,2-dithiolane-
3-pentanoic acid (C8H14O2S2) is a yellow solid organo-
sulphur compound [1]. Having an asymmetric carbon 
atom, LA exists as two enantiomers: the R-(+)-LA and S-
(–)-LA. Only the R-isomer is endogenously synthesized 
and is an essential cofactor for mitochondrial enzyme 
complexes that catalyze reaction responsible for 
oxidative glucose metabolism and cellular energy 
production. Synthetic racemic LA, a 50/50 mixture of 
R-and S-enantiomers, has been extensively used as a 
therapeutic agent in the treatment of diabetic neuro-
pathy and as an antioxidant supplement in European 
countries and the United States [2].  
Exogenously supplied LA is readily absorbed, trans-
ported to tissues and rapidly taken up by cells. Within 
the cells LA is reduced to dihydrolipoic acid (DHLA), 
then rapidly removed from cells and metabolized. 
Several lines of evidence indicated that both LA and its 
reduced form, DHLA, exerted potent antioxidant acti-
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vities, both in vitro and in vivo. In addition to direct free 
radicals scavenging and metal chelating properties, 
LA/DHLA redox couple appears to be able to regen-
erate other endogenous antioxidants such as vitamins 
C and E, and glutathione, as well as to modulate the 
redox signaling pathways [3–5]. There is evidence that 
administration of LA might have a beneficial role in a 
variety of oxidative stress conditions such as ischemia- 
-reperfusion injury, type 2 diabetes and associated 
complications, neurological disorders, ischemia-reper-
fusion injury [1].  
Human pharmacokinetic studies have found that 
oral administrated LA is characterized by rapid absorp-
tion within 1 h, short plasma half-lives, extensive hep-
atic metabolism and low and varying bioavailability [6]. 
The short half-live of LA (about 30 min) may inhibit 
effective use [7]. On the other hand, LA is unstable 
under light and heat and gradually decomposes at 
room temperature. Temperatures greater than its 
melting point (59–62 °C) cause immediate polymer-
ization and render it unusable, as polymerized LA is 
insoluble in almost all solvents [8]. Furthermore, the 
decomposition of LA is accompanied by an unpleasant 
odor due to the sulphur content [9].  
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In the past several years, a forms of stabilized and 
controlled released LA were designed with the assump-
tion that the efficacy of LA could be improved by slow-
ing the absorption and keeping blood levels of LA 
above baseline for longer periods after ingestion [10]. 
However, the efficacy and safety from sustained-rel-
ease dosage of α-lipoic acid forms have not been clear. 
Active substances such as minerals, vitamins, pro-
teins, enzymes, peptides, probiotics, phenolic com-
pounds, etc., are widely used in the food, pharmaceut-
ical and cosmetic industry nowadays [11]. These sub-
stances are very sensitive to extreme temperatures, 
presence of oxygen, microorganisms and moisture that 
often come in contact with, thereby losing their acti-
vity, both during storage and application conditions. 
Therefore, in the last few decades, a great attention 
has been put to mode the administration of active sub-
stances which should also provide the maintenance of 
their activities and their optimum (concentration) effect 
in specific parts of the body. 
One of the most common ways to overcome these 
problems is the encapsulation of these substances into 
various carriers. Encapsulation can mask the unpleas-
ant taste or smell, but also provides control of the 
release of the active substance. The main goal of 
encapsulation is to protect the substance from adverse 
conditions (light, moisture and oxygen) thereby con-
tributing to the increase of the shelf life and, at the 
same time, controlling the release and increasing the in 
vivo half-life of encapsulated product [12]. In addition 
to the choice of the appropriate method of encapsul-
ation, it is also important to choose the appropriate 
carrier. The ideal matrix for encapsulation must not 
have the degradation effect to the active substance, 
and at the same time it should be non-toxic and rel-
atively easy to synthesize. Nowadays, various systems 
for encapsulation of active substances, most often 
consisting of carbohydrates, proteins, natural or syn-
thetic polymers (chemically or physically crosslinked) 
are used among which hydrogels have become very 
popular as carriers in the various industry fields [13].  
The aim of this study was to investigate the pos-
sibility of encapsulation of LA into chitosan and algi-
nate/gelatin microparticles and to investigate its rel-
ease as this has not been studied extensively 
[10,14,15], as well as to investigate the antioxidant 
activity of released LA compared to the activity of free 
LA and its active metabolite DHLA. First part of the 
study was the attempt to encapsulate LA into chitosan 
microparticles obtained by reverse emulsion cross-
linking technique, as well as into microparticles of algi-
nate/gelatin (of various gelatin content) crosslinked 
using zinc ions. The synthesized microparticles were 
characterized by FT-IR and SEM analyses. Further on, 
the release of LA in pH simulated GI tract conditions 
were monitored followed by the experiment regarding 
in vitro antioxidant capacity of released LA expressed as 
Trolox equivalent antioxidant capacity (TEAC) and ferric 
reducing/antioxidant power (FRAP). The samples of 
plasma from healthy subjects were used for in vitro 
determination of antioxidant activities of released LA 
from selected investigated samples.  
MATERIALS AND METHODS 
Materials 
Chitosan (Ch), sodium alginate (A) and gelatin (G) 
used for microparticles preparation were obtained 
from Sigma, Japan, while itaconic acid (2-methylidene-
butanedioic acid) was purchased from Sigma–Aldrich, 
Germany. Glutaraldehyde (GA, pentane-1,5-dial), paraf-
fin oil (light liquid paraffin) and zinc chloride were 
obtained from Centrohem, Serbia. Tween 80 (polyoxy-
ethylene (20) sorbitan monooleate) used as an emul-
sifier was obtained from Riedel-de Haën, Germany. 
α-Lipoic acid (LA) (purity > 98%) was obtained from 
“Ivančić i sinovi” Belgrade, Serbia. Distilled water was 
used for the preparation of buffer solutions of pH 
2.20±0.01 (KCl/HCl, Merck) and pH 6.80±0.01 (Na2HPO4/  
/NaH2PO4, Lach-Ner). Folin–Ciocalteu reagent, ABTS 
(2,2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid 
diammonium salt), potassium persulphate, TPTZ (2,4,6- 
-Tris(2-pyridyl)-s-triazine), chloramine T trihydrate and 
peroxidase type I from horseradish were purchased 
from Sigma-Aldrich, Germany. Malonaldehyde bis(di-
methyl acetal), Trolox ((±)-6-hydroxy-2,5,7,8-tetra-
methylchromane-2-carboxylic acid) and TMB powder 
(3,3’,5,5’-tetramethylbenzidine) were purchased from 
Acros Organics. 2-Thiobarbituric acid, trichloracetic 
acid, dimethylsulfoxide (DMSO) and hydrogen peroxide 
were purchased from Merck, Germany. All other chem-
icals and reagents used were of analytical reagents 
grade quality and obtained from standard commercial 
suppliers. Dihydrolipoic acid (DHLA) was prepared by 
treating LA with NaBH4 using a method described in a 
previous report [16]. Purity was confirmed by NMR, 
comparing with literature data.  
Preparation of chitosan and alginate/gelatin 
microparticles  
Chitosan microparticles, with 1.5% (w/V) of chito-
san content crosslinked with glutaraldehyde of various 
contents (0.1–0.4 vol.%) were prepared as previously 
described [17]. The ratio of oil-to-water phases in all 
emulsion preparations was 1:5 with the addition of 2.0 
vol.% Tween 80 (1 cm3) as an emulsifier. Hydrogels of 
Na-alginate and gelatin (various ratios) in the form of 
microparticles were synthesized, as well, using Zn²+ as 
the crosslinking agent, while keeping the concentration 
of crosslinking agent constant. Namely, Na-alginate was 
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added to 14 cm3 of distilled water and allowed to dis-
solve using magnetic stirring at 500 rpm at 50 °C. After 
on, gelatin was added to the solution to reach the total 
mass of the reactants of 0.8000 g. Then the stirring 
speed was reduced to 100 rpm in order to remove air 
bubbles. For the synthesis of microparticles Syringe 
pump (New Era Pump Systems Inc., model NE-1000) 
was used. The mixture of 10 cm3 was added drop wised 
at the rate of 75 µL/min to 100 cm3 0.1 M ZnCl2 sol-
ution. During the instillation immediate formation of 
hydrogel microparticles was evident. Hydrogel micro-
particles were left for 24 h in a solution of zinc chloride 
in order to achieve complete crosslinking. After that, a 
solution of zinc chloride has been removed, and the 
hydrogel particles were washed with water three times 
and maintained in 100 cm3 of water for 24 h in order to 
remove unreacted substances. Then the synthesized 
microparticles were immersed in acetone for 30 min, 
knowing that acetone would ease the drying process 
not allowing the coalescence of microparticles. The 
particles were then removed from acetone solution 
and allowed to dry to constant weight. The compo-
sitions of all investigated samples are given in Table 1. 
Table 1. The composition of the synthesized hydrogel 
microparticles 
Sample 
Content, wt.% Crosslinking agent 
concentration, mol/dm3 Ch  A  G  
S1 2.0 – – 0.08 
S2 0.5 0.02 
S3 1.0 0.04 
S4 – 100 – 0.10 
S5 66.7 33.3 
S6 50.0 50.0 
S7 33.3 66.7 
Fourier transform infrared spectroscopy 
A Bomem MB 100 FT-IR spectrophotometer was 
used to record infrared spectra of the microparticles, 
applying the KBr disc method. Sample/KBr (ratio 1/50) 
was mixed and grounded and then compressed into a 
pellet under an 11 tones weight, for one minute, using 
Grase by Specac, model 15.011. FT-IR spectra were 
obtained in the wavenumber range 4000–400 cm–1, at 
25 °C and at 4 cm–1 spectral resolution. 
Swelling degree studies  
In order to simulate the gastrointestinal (GI) tract 
temperature and pH conditions as well as the average 
time spent in GI tract, the swelling studies were carried 
out at 37 °C, by immersing the microparticles for 2 h in 
a buffer solution of pH value of 2.20±0.01 and sub-
sequently in a buffer solution of pH 6.80±0.01 for the 
next 22 h. After immersion, microparticles’ weight was 
measured in pre-determined time intervals. The degree 
of swelling was calculated according to the following 
equation: 
q = wt/w0 (1) 
where wt corresponds to the weight of swollen micro-
particles at time t and w0 to the weight of dried micro-
particles. The swelling process was monitored gravi-
metrically. 
Scanning electron microscopy 
The surface morphology of microparticles was eva-
luated using scanning electron microscopy (Tescan 
Mira3 XMU, Cranberry Twp, PA, USA). Prior to SEM 
analysis samples were coated with gold/platinum alloy 
(15/85) under vacuum conditions, using Polaron SC502 
vacuum sputter coater. Samples were analyzed in two 
different forms: dry microparticles and rehydrated mic-
roparticles. 
Determination of encapsulation efficiency of α-lipoic 
acid 
Alpha-lipoic acid was encapsulated by immersing 
ready-made hydrogels into solution of α-lipoic acid that 
consists of 1 g of active substance dissolved into 75 cm3 
mixture of ethanol and 2 vol.% acetic acid solution 
(ratio 1:2). The pH of the obtained solution was 2.70 
offering the good environment for LA encapsulation. 
The LA encapsulation efficiency was determined spec-
trophotometrically. Encapsulation efficiency was calcul-
ated as the ratio of the actual loading, (Total LA con-
tent)e, of the hydrogel particles with α-lipoic acid and 
the theoretical loading, (Total LA content)i, using the 
following equation: 
EE(%) = (Total LA content)e/(Total LA content)i  (2) 
(Total LA content)e was calculated as the difference 
between the total amount of LA in the initial solution 
used for encapsulation and the free amount of LA left 
in the solution after encapsulation process). 
Calibration curve of LA 
A calibration curve is required for the determination 
of encapsulation efficiency and release rates of the 
microparticles. A known concentration of LA in buffers 
of pH values of 2.20 and 6.80 were scanned in the 
range of 200–500 nm by using UV/Vis spectrophoto-
meter. Prominent peaks at 329 and 332 nm were 
noticed. The concentration of LA was obtained from 
the calibration curve prepared by measuring the abs-
orbance (329 and 332 nm) of different concentrations 
of LA. 
In vitro antioxidant activity of the released LA  
The anti-oxidant capacity of released LA following in 
vitro digestion was examined by FRAP and ABTS assays. 
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The ferric reducing/antioxidant power (FRAP) assay was 
carried out according to the method described by 
Benzie and Strain [18]. The working FRAP reagent was 
prepared by mixing 300 mmol/L acetic buffer (pH 3.60), 
10 mmol/L TPTZ in 40 mmol/L HCl and 20 mmol/L 
FeCl3·6H2O in a ratio of 10:1:1. Then 200 µl of sample 
from release test medium was added to 3.80 cm3 of 
FRAP reagent. After 4 min of reaction, the absorbance 
at 593 nm was read. The FRAP values were expressed, 
taking into account a standard curve of FeSO4·7H2O and 
the results are expressed as μmol Fe(II)/gparticles. All 
measurements were performed in triplicate. 
Determination of antioxidant activity using the ABTS 
method was performed according to the method des-
cribed by Re et al. [19]. The free radical-cation ABTS•+ 
was generated by the oxidation reaction of the ABTS 
with potassium persulphate in the dark condition for 
12–16 h at room temperature. After 24 h, the absorb-
ance was adjusted with PBS pH 7.4 up to 0.70 units, at 
732 nm. For the evaluation, 20 μL of the sample was 
added to 1880 μL of the ABTS•+ and the absorbance 
readings were taken after exactly 6 min. The results 
were expressed as TEAC (trolox equivalent antioxidant 
capacity) by the construction of a standard curve, using 
several concentrations of the Trolox antioxidant. All 
measurements were performed in triplicate. 
Evaluation of antioxidant activity of LA in human 
plasma  
After night-time fasting, blood samples from 
healthy, non-smoking volunteers were collected into 
EDTA-containing sample tubes according to the ethical 
review board approved protocols. The plasma was 
pooled and used for all subsequent analysis. Tested 
solutions of native LA, its active metabolite (DHLA) and 
released LA from chitosan microparticles were added 
to the samples of plasma (0.7 cm3) and incubated for 1 
at 24 h at 37 °C. The control plasma samples (without 
tested solutions) were prepared. To evaluate the anti-
oxidant activity of the test solutions against copper 
induced oxidative stress, plasma samples were also 
incubated with copper sulphate (2 mmol/L) plus tested 
compounds and released LA added in combination. 
Incubation of plasma samples was stopped by cooling 
the samples in an ice-bath. 
The levels of lipid peroxidation products in plasma 
were assayed in plasma according to Girroti et al. [20]. 
This assay is based on the formation of a complex 
between thiobarbituric acid and malondialdehyde, an 
end product of lipid peroxidation, which absorbs at 535 
nm. Total anti-oxidant capacity (TAC) was measured in 
plasma according to Erel’s method [21]. This assay is 
based on the bleaching of the characteristic color of a 
stable 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic 
acid) radical cation (ABTS•+) by antioxidants present in 
plasma. The TAC value of the samples tested is exp-
ressed as µmol Trolox equivalent/L. Prooxidant–anti-
oxidant balance (PAB) was measured according to the 
previously published method [22], slightly modified in 
our laboratory. The assay is based on 3,3’,5,5’-tetra-
methylbenzidine and its cation, used as a redox indi-
cator participating in two simultaneous reactions. The 
standard solutions were prepared by mixing varying 
proportions of (0–100%) of 250 μmol/L hydrogen per-
oxide with 10 mmol/L uric acid. PAB is expressed in 
arbitrary HK units, which represent the percentage of 
hydrogen peroxide in the standard solution.  
Statistical analysis 
All the values were expressed as mean ± SD. The 
data were analyzed with the one-way repeated mea-
sures analysis of variances using SPSS version 18 (Chic-
ago, IL, USA).  
RESULTS AND DISCUSSION 
FT-IR analyses 
FT-IR spectra of pure chitosan microparticles were 
discussed in our earlier paper [17]. FT-IR spectra of the 
samples S4–S7 and pure gelatin are shown in Figure 1. 
From Figure 1 in the spectrum of gelatin the fol-
lowing characteristic bands occur: 3425 cm–1 (NH 
stretching vibrations), 1641 cm–1 (amide I band which 
comes mainly from the C=O stretching vibration) and 
1562 cm–1 (amide II band that comes from NH deform-
ation vibration in the plane coupled with CN stretching 
vibration). Amide III band at 1300 cm–1 comes from the 
CN stretching vibration coupled with NH deformation 
vibration) [23,24]. In the FT-IR spectrum of the sample 
S4 the most important are the following bands: 3436 
cm–1 (OH stretching vibration), 1625 cm–1 (COO asym-
metrical stretching vibration) and 1420 cm–1 (COO sym-
metrical stretching vibration) [24]. In the spectrum of 
the hydrogels containing gelatin, the absorption bands 
corresponding to the OH stretching vibration of algi-
nate (about 3430 cm–1) is shifted towards lower wave 
numbers as the content of gelatin within the samples 
increases. This is due to the formation of hydrogen 
bonding between gelatin and alginate. Also, COO asym-
metric stretching vibration of alginate at 1625 cm–1 is 
coupled with the C=O stretching vibration of gelatin, 
which caused displacement of the band corresponding 
to this vibration to higher wavenumbers as the gelatin 
content increases. At the same time, there was a shift 
of the absorption bands corresponding to the COO 
symmetric vibrations towards lower wave numbers. All 
the above mentioned shows the existence of inter-
molecular interactions between alginate and gelatin, 
caused by the formation of hydrogen bonding between 
the –COO–, –OH, –C=O and –NH2 groups of the alginate, 
and gelatin [23]. 
B.B. VIDOVIĆ et al.: ENCAPSULATION OF α-LIPOIC ACID AND ITS IN VITRO ANTIOXIDANT ACTIVITY Hem. ind. 70 (1) 49–58 (2016) 
 
53 
FT-IR spectra of selected microparticles after encap-
sulation of α-lipoic acid were given in Figure 2. 
The spectra of encapsulated LA were analyzed in 
two major regions; 3600–2800 cm–1 and 1800–445 cm–1. 
The characteristic high-intensity bands for –CH2 stretch-
ing of LA are evident around 2933 cm–1). Other charac-
teristic bands of LA at 1717 cm–1 (C=O stretching), 
already reported in the literature [25] were assumed to 
be shifted upon LA encapsulation within alginate/gel-
atin and chitosan carriers. Namely, (C=O) has been 
shifted from 1717 to 1720 or 1713 cm–1, respectively. 
The shift to lower wavenumbers can be attributed to 
the interruption of strong hydrogen bonding in LA upon 
encapsulation with alginate/gelatin carrier, showing 
relatively weak affinity for this matrice. However, shift-
ing to somewhat higher wavenumbers after encapsul-
ation of LA into chitosan matrices suggests that there is 
interaction between LA and chitosan carrier implying 
 
Figure 2. FT-IR spectra of chitosan microparticles without (S3) and with (S3’) encapsulated α-lipoic acid; alginate/gelatin 
microparticles without (S4) and with (S4’) encapsulated α-lipoic acid.
 
Figure 1. FT-IR spectra of alginate/gelatin samples (S4–S7) and pure gelatin. 
B.B. VIDOVIĆ et al.: ENCAPSULATION OF α-LIPOIC ACID AND ITS IN VITRO ANTIOXIDANT ACTIVITY Hem. ind. 70 (1) 49–58 (2016) 
54 
that carbonyl property of LA bounded to the chitosan 
support gets stronger than that of free LA. The bands at 
930 and 925 cm–1 belong to O–H vibrations of LA. A 
small shoulder peak at 1660 cm–1 appears in the spec-
trum of the LA encapsulated chitosan sample due to 
the overlapping of the carboxylic acid group in LA with 
the amide group in chitosan [14].  
The swelling kinetics 
Figure 3 shows dynamic swelling behavior of all 
samples in simulated gastric fluid of pH 2.20±0.01 for 2 
h and in intestinal fluid of pH 6.8±0.01 up to 24 h. In an 
acidic environment, the swelling rate increased since 
the chitosan amino groups were protonated (NH3+) and 
the positive charges induce repulsive forces between 
polymer chains [26]. As expected, the swelling rate was 
lower as the concentration of glutaraldehyde in chito-
san microparticles was higher (less free amino groups 
available for protonation offer lower swellability of chi-
tosan microparticles) in acidic medium. After being 
transferred to the medium of pH 6.80±0.01 chitosan 
microparticles shrunk, due to the hydrogen bonds ten-
dency to associate by changing –NH3+ into –NH2 groups, 
and after on the swelling of microparticles remained 
constant. This implies that swollen chitosan micropar-
ticles remained stable and can be used for delivery of 
low molecular weight molecules such as LA. 
 
Figure 3. The swelling kinetics of chitosan microparticles (S1 
and S3) and the effect of gelatin on the degree of swelling of 
alginate/gelatin microparticles (S4 and S5) in pH 2.20±0.01 
and 6.8±0.01 at 37 °C. 
Alginate is a natural polymer having carboxyl groups 
with pKa values of 3.38–3.65. This means that the car-
boxyl groups of the alginate are ionized at pH values 
higher than the pKa value, while at the pH below this 
value they appear in their non-ionized form. On the 
other hand, gelatin represents an amphiphilic compo-
nent that is ionized at all pH values, except at its iso-
electric point (4.8–5.5). Based on this, one would exp-
ect that the synthesized hydrogels showed significant 
swelling at higher pH values. 
At pH 2.20±0.01 carboxyl groups of the alginate are 
in non-ionized form so that there is no electrostatic 
repulsion between the functional groups, and the deg-
ree of swelling of all the samples is minute. It can be 
observed that the smallest equilibrium degree of swel-
ling has sample S4, while with increasing the gelatin 
content in the sample increases and the equilibrium 
degree of swelling. This can be explained by the fact 
that at this pH gelatin is below its isoelectric point and 
positively charged when it comes to the electrostatic 
repulsion between molecules of gelatin which causes 
an increase in hydrophilicity of the network and inc-
reases the volume of the hydrogel. Also, with the inc-
rease of gelatin concentration the possibility of aggre-
gation within the hydrogel reduces since part of the 
functional groups of alginate are already used for the 
formation of hydrogen bonds with gelatin, which 
enhances the swelling of hydrogels. 
At pH 6.80±0.01, which is higher than the pKa value 
of an alginate, carboxyl groups exist in their ionized 
form (–COO–). When the sample of pure alginate, S4 is 
placed in a phosphate buffer of pH 6.80±0.01, it comes 
to the exchange of Na+ present in the buffer solution 
with the Zn2+ bonded to the –COO– group in polyman-
nuronic segments. The electrostatic repulsion between 
–COO– groups appears thereby increasing the hydro-
philicity of the polymer chain and the swelling of the 
hydrogel. In the further process of swelling, there is an 
exchange of the Na+ with Zn2+ bound to –COO– groups 
in polyguluronic segments. As these Zn2+ are respon-
sible for crosslinking of Na-alginate and hydrogel form-
ation, the established ionic interactions are broken, the 
physical crosslinking disappears and the sample trans-
forms from the gel into solution. 
In other samples it was found that there is no com-
plete “dissolution” after 24 h. It can be seen that there 
has been a loss of mass in samples S5 (and S6, data not 
shown), indicating that some ionic interactions have 
been terminated to some extent due to exchange of 
sodium and zinc ions. Also, when increasing the con-
tent of gelatin the weight loss of the investigated mic-
roparticles is slower, increasing the stability of the gels. 
It is assumed that gelatin hinders the zinc ion exchange 
with Na+, and microparticles dissolution. With the inc-
rease of gelatin content in the samples a slight increase 
in the equilibrium degree of swelling is achieved. This 
pH values, besides the ionization of the carboxyl groups 
of the alginate, allows negative charging of gelatin 
molecules, leading to additional electrostatic repulsion 
and microparticles volume increase. 
SEM analysis 
SEM analysis was performed in order to collect 
information about morphology of chitosan and algi-
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nate/gelatin microparticles. The surface morphology is 
an important characteristic when particles come in 
contact with fluid, solid or gaseous environment and 
together with its internal structure, will influence its 
suitability for a targeted use [17]. 
Micrographs (Figure 4) reveal the surface of micro-
particles of the investigated oven-dried chitosan micro-
particles (Figure 4a), while Figure 4b shows the algi-
nate/gelatin sample without encapsulated α-lipoic acid 
swollen to equilibrium in ethanol/acetic acid mixture at 
25 °C. In order to investigate the inner structure of S4 
(Figure 4c), microparticles were freeze-dried, immersed 
in liquid nitrogen and cut.  
SEM analysis confirmed that the test particles have 
a porous surface and structure. As known that the 
appearance of the particles depends on the tempe-
rature of the medium in which the particles swell, the 
increase in temperature leads to a partial termination 
of the physical connection to the gelatin molecule due 
to the uncoiling of the triple helix, which reduces cross-
linking gelation. 
Antioxidant capacity  
The encapsulation efficiency of α-lipoic acid into 
ready-made hydrogel microparticles was in the range 
between 11.6 (S2) and 53.9% (S3). Modeling of con-
trolled release of active substances at different sites in 
the gastrointestinal (GI) tract is preferred approach for 
preventing its degradation, as well as to obtain the 
desired serum levels over the extended period of time 
[27]. Moreover, antioxidant capacity will depend on the 
release of LA via swelling and/or degradation of chito-
san microparticles. In order to explore whether the 
encapsulation influences the antioxidant capacity of LA, 
ferric reducing/antioxidant power (FRAP) assay and 
ABTS radical cation discoloration assay were per-
formed. In vitro release of LA and its antioxidant cap-
acity was evaluated in simulated gastric fluid (pH 2.20) 
and simulated intestinal fluid (pH 6.80), separately. The 
amount of released LA was determined spectrophoto-
metrically at 329 nm (pH 2.20) and 332 nm (pH 6.80). 
The obtained results are presented in Figure 5. 
The results show sustained release of LA from chito-
san microparticles (sample S3). The amount of LA rel-
 
Figure 4. SEM micrographs of microparticles without encapsulated α-lipoic acid of: a) oven-dried chitosan microparticles (S3), 
b) whole alginate/gelatin microparticles (S4) upon reaching equilibrium degree of swelling in ethanol/acetic acid mixture at 25 °C 
and c) cross-section of the alginate/gelatin (S4) microparticles. 
 
Figure 5. Antioxidant capacity of released α-lipoic acid by FRAP and ABTS assays and cumulative release of LA in simulated 
conditions of gastrointestinal tract (n = 3). 
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eased from the carrier was about 11.5 and 13.7% after 
60 and 120 min, respectively. Changing the dissolution 
medium from pH 2.2 to pH 6.8 did not result in dis-
integration of the LA chitosan microparticles in contrast 
to alginate/gelatin hydrogel microparticles (release 
data not shown), and controlled release of LA was 
achieved. After 240 min, approximately 25% of the LA 
was released after simulated dissolution test at pH 
6.80. The rate of release of LA from chitosan micro-
particles associated with observed changes in the anti-
oxidant capacity measured by FRAP and ABTS assay. 
Plasma lipid peroxidation was significantly inc-
reased in CuSO4 treated plasma samples. This incre-
ment was abolished at least in part with LA and espe-
cially with DHLA preparation. This difference between 
LA and DHLA is more evident after 24 h of incubation. 
The same pattern of influence was clear from prooxi-
dative–antioxidative balance, a parameter which showed 
the superiority of DHLA in antioxidative protection. At 
the same time, antioxidative plasma capability mea-
sured through the TAC level was abrogated upon Cu2+ 
influence and revitalized through the antioxidative LA 
and DHLA protection, which is the highest in the case of 
reduced LA formulation (DHLA).  
In this study, we assessed the effect of released LA 
from chitosan microparticles, native LA and its reduced 
metabolite (DHLA) on the modification of oxidative/  
/antioxidative balance induced by CuSO4 in vitro by 
measuring the plasma level of lipid peroxidation, the 
prooxidant-antioxidant balance levels, as well as the 
total antioxidant capacity (Figure 6). In agreement with 
previous reports, we confirmed that incubation with 
the copper increased the oxidation of plasma phos-
pholipids [28] that resulted in an elevation of levels of 
lipid peroxidation and depletion of vitamin E and other 
antioxidants in plasma [29]. The obtained results 
showed that the increase of lipid peroxidation is signi-
ficantly lower in plasma supplemented with LAs and 
 
Figure 6. The effect of LA, DHLA and LA released from chitosan microparticles on plasma lipid peroxidation level (a), total antioxi-
dative capacity (TAC) (b) and prooxidative-antioxidative balance (PAB) (c) in human plasma treated with CuSO4 as oxidative 
reactions catalyst (***p < 0.001, **p < 0.01, *p < 0.05 vs. native plasma according to repeated measures ANOVA test). 
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DHLA in the presence of cupric ion, indicating anti-
oxidant properties of LA. This effect is more evident 
after 24 h incubation of plasma samples. The same pat-
tern of influence was noticed from prooxidant-anti-
oxidant balance. At the same time, antioxidative 
plasma capability measured through the TAC level was 
abrogated upon Cu2+ influence and revitalized through 
the antioxidative LA and DHLA protection.  
CONCLUSIONS 
In conclusion, this study showed the alginate/gel-
atin hydrogel microparticles are unable to release LA in 
a controlled manner. However, the presented results 
indicated the potential benefit of using chitosan micro-
particles for controlled release of LA and sufficient anti-
oxidative protection during the prolonged period of 
time. 
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(Naučni rad) 
Alfa-liponska kiselina je organosumporno jedinjenje koje ima poznati tera-
peutski potencijal i izražena antioksidativna svojstva. Relativno kratko poluvreme
eliminacije i hemijska stabilnost α-liponske kiseline prema faktorima iz spoljašnje
sredine mogu se modifikovati njenom inkapsulacijom na čvrste nosače. Alfa-lipon-
ska kiselina iz egzogenih izvora se brzo apsorbuje, distribuira do tkiva, odnosno
ćelija u kojima se redukuje u dihidroliponsku kiselinu, a potom brzo uklanja iz
ćelija i eliminiše. Prema rezultatima in vitro i in vivo istraživanja α-liponska kiselina 
kao i njen redukovani oblik, dihidrolipoinska kiselina, imaju izražena antioksi-
dantivna svojstva. U ovom radu izvršena je inkapsulacija α-liponske kiseline u 
hitozanske mikročestice dobijene reverznom emulzionom tehnikom. Takođe, ispi-
tana je i mogućnost inkapsulacije α-liponske kiseline u mikročestice alginata i žela-
tina koje su umrežene jonima dvovalentnog cinka. Inkapsulacija α-liponske kise-
line u oba nosača izvršena je metodom bubrenja, odnosno potapanjem sinte-
tisanih suvih čestica nosača u rastvor α-liponske kiseline pod strogo kontrolisanim
uslovima. Interakcija α-liponske kiseline sa nosačima potvrđena je primenom
infracrvene spektroskopije sa Furijerovim transformacijama. Nakon inkapsulacije
α-liponske kiseline u ispitivane nosače in vitro studijom otpuštanja u simuliranim
uslovima gastrointestinalnog trakta potvrđeno je kontrolisano otpuštanje α-lipon-
ske kiseline iz hitozanskih mikročestica. Efikasnost inkapsulacije α-liponske kise-
line iznosila je do 53,9%. U in vitro eksperimentima pokazan je zadovoljavajući
nivo antioksidativne aktivnosti otpuštene α-liponske kiseline iz hitozanskih mikro-
čestica. Ovi rezultati ukazuju da hitozanske mikročestice mogu biti pogodni nosači
za kontrolisano otpuštanje α-liponske kiseline. 
  Ključne reči: Alfa-liponska kiselina • Mik-
ročestice • Hitozan • Natrijum-alginat/
/želatin • Antioksidativna aktivnost 
 
